- Current trends and considerations across cGMP manufacturing
- Optimizing production while navigating uncertain supply chain variables
- Short-term and long-term planning for effective Technical Operations
Jacob Greenwood
Vice President
Project Farma
Jacob Greenwood has spent his 15+ year professional career working in the Life Sciences industry. At Project Farma, Jacob is a strategic leader, creating and fostering client relationships and building brand awareness within the pharmaceutical and biotech industries.
In addition to his experience with Project Farma, Jacob spent 5 years as a business development professional within the Architecture, Engineering, and Construction industry, delivering projects totaling nearly $500M. Prior to developing his sales career, he was an active member of the preclinical research community, managing vivariums in both Maryland and North Carolina. Jacob remains committed to helping medicines and therapies move through the research and development stage into manufacturing and ultimately into a position to positively impact the lives of patients.
Scott Hamm
VP, Strategic Operations
Project Farma
In his role, Scott leads strategic operations, collaborating with business development, technical operations, talent acquisition and marketing to create growth for the organization. Scott is an accomplished, results-oriented leader with over 30 years of experience managing organizations and global capital projects in the life sciences industry. He is proficient in all aspects of project delivery, including planning, design, construction, commissioning, qualification, and validation, and has developed multiple procedures, best practices and tools pertaining to these activities. Scott also has a proven track record of significantly growing organizations, securing high-impact partnerships, advancing company goals and expanding footprints in the industry. He is an active ISPE member and has delivered multiple industry presentations. Scott has a BSEE degree from Purdue University and is PMP certified.
Dottie Barr
Senior Vice President Manufacturing & Technical Operations
Lantheus
Dottie Barr serves as Senior Vice President, Manufacturing and Technical Operations, joining Lantheus in 2015. Ms. Barr has served in positions of increasing responsibility at Lantheus, including most recently as Vice President of Manufacturing and Supply Chain, and brings more than 35 years of industry experience. Prior to joining Lantheus, she served as Vice President, Supply Chain, Materials, and Logistics at T2 Biosystems. She has also held positions of increasing responsibility at Haemonetics, where she ultimately rose to the position of Vice President, Global Supply Chain. Ms. Barr earned a Bachelor of Arts in economics from Framingham State University and a Master of Business Administration from Babson College. Dottie’s Philosophy “Find your passion and do what you love!
Lindsey Daniel
Head of Global Operational Excellence for Takeda’s Biologics Operating Unit
Takeda
Lindsey Daniel, PE, is the Head of Global Operational Excellence for Takeda’s Biologics Operating Unit, where she leads enterprise-wide performance improvement initiatives across a global network of manufacturing sites. With over 13 years of experience in the pharmaceutical industry, Lindsey has held leadership roles in engineering, operational excellence, and product strategy. Her leadership is grounded in a holistic approach to solving problems and a strong belief in empowering teams to own and sustain change. Lindsey is a licensed Professional Engineer (PE) and a certified Lean Six Sigma Black Belt. She is actively involved in the International Society for Pharmaceutical Engineering (ISPE), serving as the Chair of the 2026 ISPE Facilities of the Future Conference, and as the Vice President of the ISPE Boston Chapter.
—
Project Farma is a patient-focused global leader in advancing technical operations from ideation through commercialization with a proven track record of planning, building, and maintaining manufacturing facilities, capital expansions, and technical operations for complex biologics and novel modalities. We provide end-to-end services for the entire manufacturing lifecycle for pharmaceutical and biotech companies, universities, hospitals, and government agencies. Project Farma has executed 100+ facility builds, retrofits and expansions, managed 400+ large scale capital projects, industrialized 10+ commercial cell, gene, and novel therapies, and managed $6B+ in technical operations capital investments.
One of our core values is giving back. Volunteering at hospitals, supporting life science related fundraisers and partnering with nonprofit organizations is an integral part of our culture. In doing so, not only do we raise awareness of many life-threatening diseases, but we also bring our team and our client’s team closer to the actual patients and families that will be impacted by our work.
Project Farma is a PerkinElmer company. (https://www.projectfarma.com/)
